← Research analysis

Anabolic steroids

Trenbolone: potency, neuropsychiatric reports and no human trial base

Compound: TrenboloneEvidence base: Very limitedUpdated: 2026-09-07Last reviewed: September 2026By: APEDRA editorial team

Trenbolone was never developed for human use, so there is no clinical trial evidence at all. What exists in the literature is animal pharmacology plus human case reports and cohort findings on cardiac, renal and psychiatric harm among users.

Key points

  • No human clinical trial has ever evaluated trenbolone at any dose.
  • It is a potent androgen receptor agonist that does not aromatise, with strong suppression of endogenous hormone production.
  • Case reports describe acute kidney injury, cardiomyopathy and severe psychiatric symptoms in users.
  • Reported insomnia, night sweats and mood disturbance are consistent across user accounts but formally unstudied.

What the literature shows

Animal pharmacology characterises trenbolone as a highly potent anabolic agent with marked effects on nitrogen retention and body composition in livestock.

Case reports describe acute kidney injury and rhabdomyolysis in bodybuilders using trenbolone alongside other compounds.

Imaging and cohort studies of long-term anabolic steroid users report reduced cardiac function and increased coronary plaque burden, with trenbolone frequently among the compounds used.

Psychiatric literature on anabolic steroids documents hypomania, irritability, aggression and depression during use and withdrawal.

What remains unknown

  • Any dose-response relationship in humans is entirely unknown.
  • Whether cardiac and renal changes fully reverse after cessation is unclear.
  • Individual vulnerability to severe psychiatric effects cannot be predicted.

Safety and monitoring implications

  • Cardiac and renal function, blood pressure and haematocrit are the minimum monitoring if use is occurring; symptoms often appear late.
  • Sudden marked changes in mood, sleep, aggression or thinking are recognised and should prompt cessation and clinical contact.
  • Reduced urine output, dark urine or swelling warrants urgent assessment for kidney injury.

Cited literature

  1. 1.Baggish AL, Weiner RB, Kanayama G, et al. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation. Find on PubMed
  2. 2.Pope HG, Kouri EM, Hudson JI. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men. Archives of General Psychiatry. Find on PubMed
  3. 3.Daher EF, Silva Júnior GB, Queiroz AL, et al. (2009). Acute kidney injury associated with anabolic steroid and rhabdomyolysis in bodybuilders. Nephrology Dialysis Transplantation / case literature. Find on PubMed

Community reports

Anecdotal — not scientific evidence

Lived experience is valuable context and often surfaces problems before the literature does. It is also uncontrolled, unverified and subject to bias, so it never overrides published findings here.

Aggregated community threads

Mixed

Widely described as the most effective and the least comfortable compound in common use, with sleep disruption, sweating and mood volatility treated as expected.

Harm-reduction discussion groups

Negative

Frequent advice against use by first-time or younger users specifically because of the psychiatric effects reported.

Buying Trenbolone in Australia: what to check first

APEDRA does not sell Trenbolone or any other product, and takes no commission from suppliers. If you are researching where to buy it, the biggest practical risk is not the compound itself but what is actually in the bottle: under-dosing, substitution with a different compound, and contamination are all documented in independent testing of online research chemicals.

  • Ask for a batch-specific third-party lab report (HPLC/mass spectrometry), not a generic certificate.
  • Check independent review platforms, not only reviews hosted on the seller's own site.
  • Read the shipping, returns and refund policies before ordering.
  • Be wary of prices far below the market or exaggerated results claims.

Compare Australian vendors independently · how we assess suppliers

Terms used here are defined in our glossary, and the evidence-grading scale explains what this analysis's grade means. If you believe something here is wrong, tell us.

This analysis is educational. It is not medical advice, a dosing recommendation, or an endorsement of use. Speak with a qualified medical practitioner about your circumstances.